Metabolic-associated fatty liver disease and sarcopenia: A double whammy

doi:10.4254/wjh.v16.i2.152

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3732)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

2743

Figures (1-2)

190

Tables (1-2)

174

Sum=3205

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

103

Download

311

Sum=414

Feb 27, 2024 (publication date) through Jan 1, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Feb 27, 2024; 16(2): 152-163
Published online Feb 27, 2024. doi: 10.4254/wjh.v16.i2.152

Full Size Figure Download Figure

Figure 2 Clinical complications associated with metabolic-associated fatty liver disease and sarcopenia. MAFLD: Metabolic-associated fatty liver disease.

Citation: Viswanath A, Fouda S, Fernandez CJ, Pappachan JM. Metabolic-associated fatty liver disease and sarcopenia: A double whammy. World J Hepatol 2024; 16(2): 152-163
URL: https://www.wjgnet.com/1948-5182/full/v16/i2/152.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i2.152